欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3972/004
药品名称Rivaroxaban Denk
活性成分
    • Rivaroxaban 20.0 mg
剂型Film-coated tablet
上市许可持有人Denk Pharma GmbH & Co. KG Prinzregentenstrasse 79 München, 81675, Germany
参考成员国 - 产品名称Netherlands (NL)
Rivaroxaban Denk 20 mg filmomhulde tabletten
互认成员国 - 产品名称
    • Germany (DE)
      Rivaroxaban Denk 20 mg Filmtabletten
    • Malta (MT)
      Rivaroxaban Denk 20mg filmc-oated tablets
许可日期2017/10/16
最近更新日期2024/12/20
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase